News

Filter

Current filters:

Etoposide

1 to 9 of 38 results

Samaritan licenses US PBR patent

03-09-2007

Las Vegas, Nevada, USA-based Samaritan Pharmaceuticals has entered into an exclusive licensing agreement…

EtoposideVePesid

Lilly's Almita enters Ph III trial for SCLC

30-10-2006

US drugmaker Eli Lilly says that it has initiated a Phase III trial of its anticancer agent Alimta (pemetrexed…

AlimtaAmino AcidsCarboplatinCisplatinCisplatin InjectionEtoposideInjectionLillyParaplatinPemetrexedPhysostigmine SalicylateVePesid

Additional appros for Nippon Kayaku's anti-tumor agents

28-02-2005

Japanese drumaker Nippon Kayaku has received approval in Japan for additional indications for its anti-tumor…

EtoposideVePesid

GW gel prevents chemo-related alopecia

06-04-2000

Glaxo Wellcome's cyclin-dependent kinase 2 inhibitor, GW8510, has beenfound to prevent alopecia in animals…

EtoposideVePesid

Cell Therapeutics suffers on lisofylline trial data, cuts development

14-10-1999

Cell Therapeutics Inc's investigational compound lisofylline has failedto meet its primary endpoint,…

Bristol-Myers SquibbEtoposideJohnson & JohnsonPaclitaxelTaxolVePesid

Amdray shows promise in Phase II

04-03-1999

Novartis' multidrug resistance modulator Amdray (valspodar; previouslyPSC 833) has shown promising results…

CytarabineEtoposideNovartisVePesid

1 to 9 of 38 results

COMPANY SPOTLIGHT

Menarini

Back to top